Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Manuel Francisco Ugarte-GilJohn HanlyMurray B UrowitzCaroline GordonSang-Cheol BaeJuanita Romero-DiazJorge Sanchez-GuerreroSasha BernatskyAnn Elaine ClarkeDaniel J WallaceDavid Alan IsenbergAnisur RahmanJoan T MerrillPaul R FortinDafna D GladmanIan N BruceMichelle A PetriEllen M GinzlerMary Anne DooleyRosalind Ramsey-GoldmanSusan ManziAndreas JönsenRonald F Van VollenhovenCynthia AranowMeggan MackayGuillermo Ruiz-IrastorzaSam LimMurat InançKen KalunianSøren JacobsenChristine PeschkenDiane L KamenAnca AskanaseBernardo A Pons-EstelGraciela S AlarconPublished in: Annals of the rheumatic diseases (2022)
Remission on-treatment and off-treatment, LDA-TC and mLLDAS were associated with less damage accrual, even adjusting for possible confounders and effect modifiers.